These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 190420)

  • 21. LH responses to LHRH, DBcAMP, and 17 beta-estradiol in cultures derived from aged rats.
    Tang LK; Tang FY
    Am J Physiol; 1981 May; 240(5):E510-8. PubMed ID: 6263104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long acting cAMP analogues enhance sulfate incorporation into matrix proteoglycans and suppress cell division of fetal rat chondrocytes in monolayer culture.
    Miller RP; Husain M; Lohin S
    J Cell Physiol; 1979 Jul; 100(1):63-76. PubMed ID: 224070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolactin binding to R3230AC mammary carcinoma and liver in hormone-treated and diabetic rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1977 Feb; 37(2):595-8. PubMed ID: 188551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of hepatoma cell growth by analogs of adenosine and cyclic AMP and the influence of enzymes in mammalian sera.
    Hargrove JL; Granner DK
    J Cell Physiol; 1982 Jun; 111(3):232-8. PubMed ID: 6124549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of 17 beta-estradiol on pituitary cAMP binding and responses to DBcAMP.
    Tang LK; Tang FY
    Am J Physiol; 1981 Mar; 240(3):E297-301. PubMed ID: 6259948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonistic action between cyclic adenosine 3':5'-monophosphate and estrogen in rat mammary tumor growth control.
    Cho-Chung YS
    Cancer Res; 1978 Nov; 38(11 Pt 2):4071-5. PubMed ID: 212186
    [No Abstract]   [Full Text] [Related]  

  • 27. Cyclic adenosine 3',5'-monophosphate-binding protein: role in ovariectomy-induced regression of a hormone-dependent mammary tumor in Sprague-Dawley female rats.
    Cho-Chung YS; Bodwin JS; Clair T
    J Natl Cancer Inst; 1978 May; 60(5):1175-8. PubMed ID: 205664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Major proteins and secretory character of the rough endoplasmic reticulum of a mouse mammary adenocarcinoma.
    Slaby F; Slaby M
    Cancer Res; 1976 Oct; 36(10):3634-8. PubMed ID: 986239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ectopic growth hormone-releasing factor and dibutyryl cyclic adenosine monophosphate-stimulated growth hormone release in vitro: effects of corticosterone and estradiol.
    Webb CB; Szabo M; Frohman LA
    Endocrinology; 1983 Oct; 113(4):1191-6. PubMed ID: 6311512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of transforming growth factor alpha (TGF alpha) in differentiated rat mammary tumors: estrogen induction of TGF alpha production.
    Liu SC; Sanfilippo B; Perroteau I; Derynck R; Salomon DS; Kidwell WR
    Mol Endocrinol; 1987 Oct; 1(10):683-92. PubMed ID: 2484711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dibutyryl cyclic AMP treatment mimics ovariectomy: new genomic regulation in mammary tumor regression.
    Huang FL; Cho-Chung YS
    Biochem Biophys Res Commun; 1982 Jul; 107(1):411-5. PubMed ID: 6289828
    [No Abstract]   [Full Text] [Related]  

  • 32. Enhancement by retinoic acid and dibutyryl cyclic adenosine 3':5'-monophosphate of the differentiation and gene expression of human neuroblastoma cells induced by interferon.
    Higuchi T; Hannigan GE; Malkin D; Yeger H; Williams BR
    Cancer Res; 1991 Aug; 51(15):3958-64. PubMed ID: 1677311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some effects of dibutyryl cyclic adenosine monophosphate (DBcAMP) on rabbit bone marrow cells in culture: cell clumping and cholinesterase production.
    Garry VF; Harris LW; Petrali JP
    Oncology; 1974; 30(6):517-28. PubMed ID: 4143262
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of estrogen to alter amino acid transport in R3230AC mammary carcinomas and its relationship to insulin action.
    Hissin PJ; Hilf R
    Cancer Res; 1979 Sep; 39(9):3381-7. PubMed ID: 157804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
    J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual secretory and myoepithelial differentiation in the transplantable R3230AC rat mammary carcinoma.
    Papotti M; Coda R; Ottinetti A; Bussolati G
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 55(1):39-45. PubMed ID: 2898832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like growth factor-binding proteins in R3230AC mammary tumors of intact and diabetic rats.
    Korc-Grodzicki B; Ren N; Hilf R
    Endocrinology; 1993 Nov; 133(5):2362-70. PubMed ID: 7691588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The novel tubulin-binding drug BTO-956 inhibits R3230AC mammary carcinoma growth and angiogenesis in Fischer 344 rats.
    Shan S; Lockhart AC; Saito WY; Knapp AM; Laderoute KR; Dewhirst MW
    Clin Cancer Res; 2001 Aug; 7(8):2590-6. PubMed ID: 11489843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrastructural changes in porcine mammary tissue during lactogenesis.
    Kensinger RS; Collier RJ; Bazer FW
    J Anat; 1986 Apr; 145():49-59. PubMed ID: 3429308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that the inhibition of TE85 human bone cell proliferation by agents which stimulate cAMP production may in part be mediated by changes in the IGF-II regulatory system.
    Mohan S; Baylink DJ
    Growth Regul; 1991 Sep; 1(3):110-8. PubMed ID: 1726835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.